Open | 1.18 |
Previous Close | 1.16 |
Day Range | 1.13 - 1.22 |
52-Week Range | 1.16 - 6.78 |
All-Time High | 43.32 |
Avg. Volume (50-day) | 640,144.06 |
EPS (TTM) | -1.24 |
Next Earnings Date | 2025-05-08 (AMC) |
Last Earnings Date | 2025-02-26 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.94 |
PEG Ratio | 1.31 |
Price to Book | 0.91 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 100.56 M |
Revenue per Share (TTM) | 1.02 |
Shares Outstanding | 99.086 M |
Share Float (%) | 74.94 M |
% Held by Institutions | 68.31 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 1.36 (-11.03%) |
+/- SMA(50) | 1.56 (-22.44%) |
+/- SMA(200) | 3.64 (-66.76%) |
5-Day Perf. | -6.92% |
1-Month Perf. | -26.22% |
3-Month Perf. | -35.98% |
6-Month Perf. | -73.11% |
YTD Perf. | -35.98% |
1-Year Perf. | -79.21% |
RSI(14) | 36.34 |
ATR(14) | 0.11 |
ADX(14) | 15.6 |
Beta (5Y) | 1.50 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
ALEC has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
Elder Bar Turned Blue |
New 52-week Lows |
Bullish Engulfing |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.